Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Net Acquisitions/Divestitures 2010-2025 | MKKGY

Merck annual/quarterly net acquisitions/divestitures history and growth rate from 2010 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
  • Merck net acquisitions/divestitures for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Merck net acquisitions/divestitures for the twelve months ending March 31, 2025 were $-1.447B, a 6249.73% increase year-over-year.
  • Merck annual net acquisitions/divestitures for 2024 were $-0.838B, a 6348.61% increase from 2023.
  • Merck annual net acquisitions/divestitures for 2023 were $-0.013B, a 97.95% decline from 2022.
  • Merck annual net acquisitions/divestitures for 2022 were $-0.632B, a 13259.26% increase from 2021.
  
Merck Annual Net Acquisitions/Divestitures
(Millions of US $)
2024 $-838
2023 $-13
2022 $-632
2021 $-5
2020 $-13
2019 $-5,622
2018 $3,695
2017 $-19
2016 $-173
2015 $-14,961
2014 $-1,887
2013 $-20
2012 $-26
2011 $N/A
2010 $N/A
2009 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.407B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $67.696B 26.04
Zoetis (ZTS) United States $65.303B 23.69
Daiichi Sankyo, - (DSNKY) Japan $46.222B 23.69
Takeda Pharmaceutical (TAK) Japan $45.947B 9.38
BeOne Medicines - (ONC) Cayman Islands $31.585B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.846B 0.00
Summit Therapeutics (SMMT) United States $21.285B 0.00
Shionogi (SGIOY) Japan $15.227B 0.00
United Therapeutics (UTHR) United States $13.600B 11.77
Neurocrine Biosciences (NBIX) United States $12.399B 36.99
Orion OYJ (ORINY) Finland $10.757B 25.92
IPSEN (IPSEY) France $10.413B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.676B 0.00
Corcept Therapeutics (CORT) United States $7.618B 63.98
Grifols, S.A (GRFS) Spain $7.329B 0.00
Stevanato Group S.p.A (STVN) Italy $7.156B 42.20
Ionis Pharmaceuticals (IONS) United States $6.637B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.376B 0.00
Hypermarcas (HYPMY) Brazil $2.869B 21.57
NewAmsterdam Pharma (NAMS) Netherlands $2.842B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.677B 12.75
Crinetics Pharmaceuticals (CRNX) United States $2.529B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.431B 8.14
Centessa Pharmaceuticals (CNTA) United Kingdom $2.274B 0.00
Ocular Therapeutix (OCUL) United States $2.124B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.742B 0.00
ARS Pharmaceuticals (SPRY) United States $1.719B 0.00
Dyne Therapeutics (DYN) United States $1.588B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.497B 22.29
Evotec AG (EVO) Germany $1.396B 0.00
Guardian Pharmacy Services (GRDN) United States $1.264B 0.00
Harrow (HROW) United States $1.263B 0.00
Ardelyx (ARDX) United States $1.256B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.233B 0.00
Xeris Biopharma Holdings (XERS) United States $1.105B 0.00
Collegium Pharmaceutical (COLL) United States $1.100B 6.01
Akebia Therapeutics (AKBA) United States $0.907B 0.00
Cronos Group (CRON) Canada $0.883B 0.00
Enliven Therapeutics (ELVN) United States $0.868B 0.00
ProKidney (PROK) United States $0.758B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.681B 0.00
Zevra Therapeutics (ZVRA) United States $0.657B 0.00
Siga Technologies (SIGA) United States $0.642B 7.93
Elite Pharmaceuticals (ELTP) United States $0.626B 0.00
KalVista Pharmaceuticals (KALV) United States $0.620B 0.00
Organogenesis (ORGO) United States $0.578B 0.00
Theravance Biopharma (TBPH) United States $0.576B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.569B 5.86
Bioventus (BVS) United States $0.568B 13.84
Relay Therapeutics (RLAY) United States $0.555B 0.00
Tourmaline Bio (TRML) United States $0.532B 0.00
USANA Health Sciences (USNA) United States $0.527B 10.81
Xencor (XNCR) United States $0.516B 0.00
Oruka Therapeutics (ORKA) United States $0.490B 0.00
Savara (SVRA) United States $0.456B 0.00
Aquestive Therapeutics (AQST) United States $0.387B 0.00
Esperion Therapeutics (ESPR) United States $0.371B 0.00
Nanobiotix S.A (NBTX) France $0.354B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.342B 0.00
AleAnna (ANNA) United States $0.325B 0.00
Aldeyra Therapeutics (ALDX) United States $0.315B 0.00
Larimar Therapeutics (LRMR) United States $0.296B 0.00
Nektar Therapeutics (NKTR) United States $0.286B 0.00
Altimmune (ALT) United States $0.280B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 17.82
Galectin Therapeutics (GALT) United States $0.263B 0.00
4D Molecular Therapeutics (FDMT) United States $0.261B 0.00
OmniAb (OABI) United States $0.241B 0.00
Heron Therapeutics (HRTX) United States $0.201B 0.00
MediWound (MDWD) Israel $0.201B 0.00
China SXT Pharmaceuticals (SXTC) China $0.184B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
Journey Medical (DERM) United States $0.176B 0.00
Lyell Immunopharma (LYEL) United States $0.170B 0.00
MEI Pharma (MEIP) United States $0.168B 0.00
Profound Medical (PROF) Canada $0.166B 0.00
Lexeo Therapeutics (LXEO) United States $0.150B 0.00
Korro Bio (KRRO) United States $0.150B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.145B 22.42
Protara Therapeutics (TARA) United States $0.121B 0.00
Avalo Therapeutics (AVTX) United States $0.117B 0.00
Liminatus Pharma (LIMN) United States $0.115B 0.00
Avita Medical (RCEL) United States $0.112B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Inhibikase Therapeutics (IKT) United States $0.106B 0.00
Cassava Sciences (SAVA) United States $0.105B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.103B 0.00
Champions Oncology (CSBR) United States $0.088B 20.03
VAXART, INC (VXRT) United States $0.087B 0.00
Achieve Life Sciences (ACHV) Canada $0.087B 0.00
ESSA Pharma (EPIX) Canada $0.085B 0.00
Dominari Holdings (DOMH) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Surrozen (SRZN) United States $0.082B 0.00
Vivani Medical (VANI) United States $0.082B 0.00
Cardiol Therapeutics (CRDL) Canada $0.082B 0.00
Nutriband (NTRB) United States $0.080B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Metagenomi (MGX) United States $0.072B 0.00
BioNxt Solutions (BNXTF) Canada $0.071B 0.00
Assertio Holdings (ASRT) United States $0.070B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.065B 0.00
Inotiv (NOTV) United States $0.063B 0.00
Wellgistics Health (WGRX) United States $0.061B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Rafael Holdings (RFL) United States $0.057B 0.00
Unicycive Therapeutics (UNCY) United States $0.052B 0.00
PolyPid (PYPD) Israel $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 29.36
Plus Therapeutics (PSTV) United States $0.048B 0.00
Fractyl Health (GUTS) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.044B 0.00
NRx Pharmaceuticals (NRXP) United States $0.044B 0.00
Klotho Neurosciences (KLTO) United States $0.042B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
FibroGen (FGEN) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.034B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
Enlivex Therapeutics (ENLV) Israel $0.034B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Mural Oncology (MURA) Ireland $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
Incannex Healthcare (IXHL) Australia $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
BioVie (BIVI) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 12.36
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00